[
  {
    "question": "治療 mental disorder 的藥物作用於哪些基因？",
    "gold_answers": [
      "CALM1",
      "ADRA2B",
      "BCHE",
      "CHRM3",
      "HTR2C",
      "HTR2B",
      "ADRA1A",
      "ADRA1D",
      "DRD2",
      "ADRA2A",
      "DRD1",
      "HTR2A",
      "CYP1A2",
      "ABCB1",
      "ALB",
      "KCNH2",
      "ORM1",
      "ADRA2C",
      "HTR6",
      "ADRA1B",
      "CYP2E1",
      "HRH1",
      "ABCB11",
      "DRD3",
      "CYP3A4",
      "DRD4",
      "ORM2",
      "HTR1A",
      "CHRM1",
      "DRD5",
      "HTR7",
      "SMPD1",
      "CYP2D6",
      "HRH4",
      "CHRM2",
      "ABCC2",
      "BIRC5",
      "SLC18A1",
      "SLC22A2",
      "SLC18A2",
      "SLCO1B1",
      "CYP3A5",
      "SLC22A1",
      "SLCO2B1",
      "CYP1A1",
      "GRIN2B",
      "SIGMAR1",
      "CYP2C9",
      "CBR1",
      "UGT1A9",
      "MCHR1",
      "CYP2C19",
      "CYP3A7",
      "HTR1D",
      "AR"
    ],
    "retrieved_context": [
      "mental disorder disease_protein DRD5",
      "DRD5 disease_protein mental disorder",
      "psychiatric disorder disease_protein MAOA",
      "mental disorder indication Chlorpromazine",
      "mental disorder indication Fluphenazine",
      "mental disorder indication Chlorpromazine drug_protein CALM1",
      "mental disorder indication Chlorpromazine drug_protein ADRA2B",
      "mental disorder indication Chlorpromazine drug_protein BCHE",
      "mental disorder indication Chlorpromazine drug_protein CHRM3",
      "mental disorder indication Chlorpromazine drug_protein HTR2C",
      "mental disorder indication Chlorpromazine drug_protein CALM1",
      "mental disorder indication Chlorpromazine drug_protein ADRA2B",
      "mental disorder indication Chlorpromazine drug_protein BCHE",
      "mental disorder indication Chlorpromazine drug_protein CHRM3",
      "mental disorder indication Chlorpromazine drug_protein HTR2C",
      "mental disorder indication Chlorpromazine drug_protein CALM1",
      "mental disorder indication Chlorpromazine drug_protein ADRA2B",
      "mental disorder indication Chlorpromazine drug_protein BCHE",
      "mental disorder indication Chlorpromazine drug_protein CHRM3",
      "mental disorder indication Chlorpromazine drug_protein HTR2C"
    ],
    "llm_answer": "CALM1, ADRA2B, BCHE, CHRM3, HTR2C",
    "pred_genes": [
      "CALM1",
      "ADRA2B",
      "BCHE",
      "CHRM3",
      "HTR2C"
    ],
    "precision": 1.0,
    "recall": 0.09090909090909091,
    "f1": 0.16666666666666669
  },
  {
    "question": "治療 gingivitis 的藥物作用於哪些基因？",
    "gold_answers": [
      "SLC22A6",
      "ALB",
      "SLC22A8",
      "SLC22A7",
      "SLC22A11",
      "PADI4",
      "CYP3A4",
      "SLCO2B1",
      "SLC15A1",
      "SLC22A5",
      "SLC15A2",
      "SLC22A4",
      "SLCO1B1",
      "SLCO3A1",
      "SLCO4A1",
      "ABCC2",
      "ABCG2",
      "ABCB11",
      "UGT1A1",
      "CYP2D6",
      "MAPK14",
      "NOS2",
      "MAPK1",
      "VEGFA",
      "MAPK9",
      "MAPK3",
      "MAPK8",
      "IL1B",
      "MAPK6",
      "MAPK12",
      "MAPK7",
      "CASP3",
      "CASP1",
      "MAPK10",
      "MMP9",
      "ALOX5",
      "CYCS",
      "MAPK11",
      "MAPK13",
      "MAPK4",
      "MAPK15",
      "AVPR2"
    ],
    "retrieved_context": [
      "Gatifloxacin drug_effect Gingivitis",
      "gingivitis indication Fusidic acid",
      "Gadoteridol drug_effect Gingivitis",
      "fibromatosis, gingival disease_protein GINGF2",
      "Nicotine drug_effect Gingivitis",
      "necrotizing ulcerative gingivitis indication Ciprofloxacin drug_protein CYP1A2",
      "necrotizing ulcerative gingivitis indication Ciprofloxacin drug_protein ABCB1",
      "necrotizing ulcerative gingivitis indication Ciprofloxacin drug_protein ALB",
      "necrotizing ulcerative gingivitis indication Ciprofloxacin drug_protein KCNH2",
      "necrotizing ulcerative gingivitis indication Ciprofloxacin drug_protein TOP2A",
      "nicotine dependence indication Bupropion drug_protein SLC6A3",
      "nicotine dependence indication Bupropion drug_protein HTR3A",
      "nicotine dependence indication Bupropion drug_protein ORM1",
      "nicotine dependence indication Bupropion drug_protein CHRNA3",
      "nicotine dependence indication Bupropion drug_protein CYP2B6"
    ],
    "llm_answer": "CYP1A2, ABCB1, ALB, KCNH2, TOP2A",
    "pred_genes": [
      "CYP1A2",
      "ABCB1",
      "ALB",
      "KCNH2",
      "TOP2A"
    ],
    "precision": 0.2,
    "recall": 0.023809523809523808,
    "f1": 0.0425531914893617
  },
  {
    "question": "治療 hereditary angioedema 的藥物作用於哪些基因？",
    "gold_answers": [
      "NR3C1",
      "CYP2C8",
      "SERPINA6",
      "CYP19A1",
      "ABCB1",
      "ALB",
      "CYP2B6",
      "CYP2C9",
      "CYP3A4",
      "CYP2A6",
      "CYP3A5",
      "CYP2C19",
      "CYP3A7",
      "CYP1B1",
      "BCHE",
      "PTGS2",
      "HSD11B1",
      "SLCO1A2",
      "CYP3A43",
      "ANXA1",
      "SHBG",
      "SLC22A8",
      "AKR1D1",
      "SRD5A2",
      "HSD11B2",
      "CYP11B2",
      "CYP11B1",
      "ABCG2",
      "HSD3B1",
      "CYP1A1",
      "NOS2",
      "ABCC2",
      "NR1I2",
      "CYP17A1",
      "CYP4A11",
      "CYP2E1",
      "NR0B1",
      "ABCB11",
      "HTR2C",
      "ADRA1A",
      "DRD2",
      "HTR2A",
      "CYP1A2",
      "HRH1",
      "CHRM1",
      "CYP2D6",
      "F2",
      "F11",
      "PLAT",
      "C1R",
      "C1S",
      "KLKB1",
      "F12",
      "AR",
      "BDKRB2",
      "ANPEP"
    ],
    "retrieved_context": [
      "C1S disease_protein hereditary angioedema",
      "hereditary angioedema indication Ecallantide",
      "hereditary angioedema indication Prednisolone",
      "angioedema disease_protein IL18",
      "hereditary angioedema indication Icatibant",
      "hereditary angioedema indication Betamethasone drug_protein NR3C1",
      "hereditary angioedema indication Betamethasone drug_protein CYP2C8",
      "hereditary angioedema indication Betamethasone drug_protein SERPINA6",
      "hereditary angioedema indication Betamethasone drug_protein CYP19A1",
      "hereditary angioedema indication Betamethasone drug_protein ABCB1",
      "hereditary angioedema indication Betamethasone drug_protein NR3C1",
      "hereditary angioedema indication Betamethasone drug_protein CYP2C8",
      "hereditary angioedema indication Betamethasone drug_protein SERPINA6",
      "hereditary angioedema indication Betamethasone drug_protein CYP19A1",
      "hereditary angioedema indication Betamethasone drug_protein ABCB1",
      "renin-angiotensin-aldosterone system-blocker-induced angioedema indication Betamethasone drug_protein NR3C1",
      "renin-angiotensin-aldosterone system-blocker-induced angioedema indication Betamethasone drug_protein CYP2C8",
      "renin-angiotensin-aldosterone system-blocker-induced angioedema indication Betamethasone drug_protein SERPINA6",
      "renin-angiotensin-aldosterone system-blocker-induced angioedema indication Betamethasone drug_protein CYP19A1",
      "renin-angiotensin-aldosterone system-blocker-induced angioedema indication Betamethasone drug_protein ABCB1",
      "hereditary angioedema indication Betamethasone drug_protein NR3C1",
      "hereditary angioedema indication Betamethasone drug_protein CYP2C8",
      "hereditary angioedema indication Betamethasone drug_protein SERPINA6",
      "hereditary angioedema indication Betamethasone drug_protein CYP19A1",
      "hereditary angioedema indication Betamethasone drug_protein ABCB1"
    ],
    "llm_answer": "KLKB1, BDKRB2, NR3C1, CYP2C8, SERPINA6, CYP19A1, ABCB1",
    "pred_genes": [
      "KLKB1",
      "BDKRB2",
      "NR3C1",
      "CYP2C8",
      "SERPINA6",
      "CYP19A1",
      "ABCB1"
    ],
    "precision": 1.0,
    "recall": 0.125,
    "f1": 0.2222222222222222
  },
  {
    "question": "治療 sarcoidosis 的藥物作用於哪些基因？",
    "gold_answers": [
      "NR3C1",
      "CYP2C8",
      "SERPINA6",
      "CYP19A1",
      "ABCB1",
      "ALB",
      "CYP2B6",
      "CYP2C9",
      "CYP3A4",
      "CYP2A6",
      "CYP3A5",
      "CYP2C19",
      "CYP3A7",
      "CYP1B1",
      "BCHE",
      "PTGS2",
      "HSD11B1",
      "SLCO1A2",
      "CYP3A43",
      "ANXA1",
      "SHBG",
      "SLC22A8",
      "AKR1D1",
      "SRD5A2",
      "HSD11B2",
      "CYP11B2",
      "CYP11B1",
      "ABCG2",
      "HSD3B1",
      "CYP1A1",
      "NOS2",
      "ABCC2",
      "NR1I2",
      "CYP17A1",
      "CYP4A11",
      "CYP2E1",
      "NR0B1",
      "ABCB11"
    ],
    "retrieved_context": [
      "sarcoidosis disease_protein SOD2",
      "IL18 disease_protein sarcoidosis",
      "sarcoglycanopathy disease_protein SGCA",
      "SART3 disease_protein porokeratosis (disease)",
      "porokeratosis (disease) disease_protein SART3",
      "sarcoidosis indication Betamethasone drug_protein NR3C1",
      "sarcoidosis indication Betamethasone drug_protein CYP2C8",
      "sarcoidosis indication Betamethasone drug_protein SERPINA6",
      "sarcoidosis indication Betamethasone drug_protein CYP19A1",
      "sarcoidosis indication Betamethasone drug_protein ABCB1"
    ],
    "llm_answer": "NR3C1, CYP2C8, SERPINA6, CYP19A1, ABCB1",
    "pred_genes": [
      "NR3C1",
      "CYP2C8",
      "SERPINA6",
      "CYP19A1",
      "ABCB1"
    ],
    "precision": 1.0,
    "recall": 0.13157894736842105,
    "f1": 0.23255813953488372
  },
  {
    "question": "治療 epilepsy with generalized tonic-clonic seizures 的藥物作用於哪些基因？",
    "gold_answers": [
      "COMT",
      "GABRG2",
      "CYP2C8",
      "GABRA3",
      "GABRE",
      "CACNB4",
      "CACNA1F",
      "CYP2C18",
      "UGT1A4",
      "CACNB3",
      "ABCC2",
      "NR1I2",
      "NQO1",
      "CYP1A2",
      "ABCB1",
      "GABRB3",
      "ALB",
      "EPHX1",
      "KCNH2",
      "CACNB1",
      "CYP2B6",
      "GABRA4",
      "CACNA1A",
      "GABRA1",
      "GABRD",
      "CACNA1S",
      "CACNA1C",
      "GABRA6",
      "GABRA5",
      "CYP2C9",
      "SCN1B",
      "CYP2E1",
      "CACNB2",
      "SERPINA7",
      "CYP3A4",
      "UGT1A6",
      "UGT1A9",
      "SCN2A",
      "GABRB1",
      "CYP2A6",
      "SCN5A",
      "CACNA1D",
      "SCN3A",
      "SCN1A",
      "CYP3A5",
      "GABRA2",
      "GABRB2",
      "CYP2C19",
      "CYP3A7",
      "UGT1A1",
      "SLCO1C1",
      "CYP2D6",
      "GABRG1",
      "SCN8A",
      "GABRQ",
      "GABRG3",
      "GABRP",
      "CYP11B1",
      "PRKAB2",
      "PRKAA2",
      "CA1",
      "CA3",
      "PRKAA1",
      "GRIK3",
      "PRKAB1",
      "GRIK5",
      "CACNA1E",
      "CA4",
      "PRKAG1",
      "GRIK2",
      "CA2",
      "SCN4A",
      "PRKAG2",
      "GRIK1",
      "PRKAG3",
      "GRIK4",
      "SCN10A",
      "SCN11A",
      "SCN9A",
      "SCN7A",
      "UGT2B7",
      "RALBP1",
      "CHRNA4",
      "UGT1A7",
      "CYP1A1",
      "GRIA2",
      "GRIN2B",
      "ABCC1",
      "ABCB11",
      "GRIN1",
      "GRIN2C",
      "GRIN2A",
      "GRIN2D",
      "CYP4B1",
      "ABCC3",
      "CHRNA7",
      "GRIN3A",
      "SLCO2A1",
      "GRIN3B",
      "UGT1A8",
      "TRPM3",
      "UGT1A10",
      "UGT2B15",
      "UGT1A3",
      "UGT2B4"
    ],
    "retrieved_context": [
      "BCHE disease_protein epilepsy with generalized tonic-clonic seizures",
      "NGF disease_protein epilepsy with generalized tonic-clonic seizures",
      "epilepsy with generalized tonic-clonic seizures disease_protein NGF",
      "epilepsy with generalized tonic-clonic seizures indication Carbamazepine",
      "epilepsy with generalized tonic-clonic seizures indication Ethotoin",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein COMT",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRG2",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein CYP2C8",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRA3",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRE",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein COMT",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRG2",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein CYP2C8",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRA3",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRE",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein COMT",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRG2",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein CYP2C8",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRA3",
      "epilepsy with generalized tonic-clonic seizures indication Phenytoin drug_protein GABRE"
    ],
    "llm_answer": "COMT,GABRG2,CYP2C8,GABRA3,GABRE",
    "pred_genes": [
      "COMT",
      "GABRG2",
      "CYP2C8",
      "GABRA3",
      "GABRE"
    ],
    "precision": 1.0,
    "recall": 0.047619047619047616,
    "f1": 0.0909090909090909
  },
  {
    "question": "治療 urinary bladder neoplasm 的藥物作用於哪些基因？",
    "gold_answers": [
      "BCHE",
      "CYP2B6",
      "CYP3A4",
      "TOP2A"
    ],
    "retrieved_context": [
      "ATM disease_protein bladder benign neoplasm",
      "NCAN disease_protein non-papillary transitional cell carcinoma of the bladder",
      "NCAN disease_protein urinary bladder neoplasm",
      "ACHE disease_protein urinary bladder neoplasm",
      "ATM disease_protein bladder carcinoma in situ",
      "headache disorder indication Acetaminophen drug_protein PTGES3",
      "headache disorder indication Acetaminophen drug_protein SULT1A1",
      "headache disorder indication Acetaminophen drug_protein GSTP1",
      "headache disorder indication Acetaminophen drug_protein CYP1A2",
      "headache disorder indication Acetaminophen drug_protein ABCB1"
    ],
    "llm_answer": "",
    "pred_genes": [],
    "precision": 0,
    "recall": 0.0,
    "f1": 0
  },
  {
    "question": "治療 Prinzmetal angina 的藥物作用於哪些基因？",
    "gold_answers": [
      "CYP2C8",
      "ABCB1",
      "ALB",
      "ORM1",
      "CACNG1",
      "CACNA1C",
      "CYP3A4",
      "CYP3A5",
      "CYP2C19",
      "CYP3A7",
      "CYP2D6",
      "CYP2C18",
      "ADRA1A",
      "ADRA1D",
      "SLC6A4",
      "CACNA1B",
      "ABCC1",
      "SLC22A5",
      "ABCC4",
      "CYP1A2",
      "KCNH2",
      "CYP2B6",
      "SLC22A4",
      "ADRA1B",
      "CACNA1A",
      "KCNJ11",
      "CYP2C9",
      "CYP2E1",
      "CACNA1G",
      "CACNA1H",
      "SLCO1A2",
      "SLCO1B1",
      "SLC47A1",
      "SLC22A1",
      "ABCC3",
      "ABCC10",
      "SLC47A2",
      "HDAC2",
      "ABCC2",
      "HMGCR",
      "AHR",
      "NR1I3",
      "DPP4",
      "ABCB11",
      "ABCC5",
      "UGT1A1",
      "UGT1A3",
      "SLCO1B3",
      "SLCO2B1",
      "CALM1",
      "CYP1A1",
      "NR1I2",
      "KCND3",
      "CACNA1S",
      "CACNB2",
      "ORM2",
      "CYP2A6",
      "CACNA1D",
      "CACNA1I",
      "CA1",
      "CACNB1",
      "SMPD1",
      "CACNA2D3"
    ],
    "retrieved_context": [
      "Prinzmetal angina indication Atorvastatin",
      "Prinzmetal angina indication Nifedipine",
      "Prinzmetal angina indication Verapamil",
      "Prinzmetal angina indication Amlodipine",
      "Prinzmetal angina indication Diltiazem",
      "Prinzmetal angina indication Diltiazem drug_protein CYP2C8",
      "Prinzmetal angina indication Diltiazem drug_protein ABCB1",
      "Prinzmetal angina indication Diltiazem drug_protein ALB",
      "Prinzmetal angina indication Diltiazem drug_protein ORM1",
      "Prinzmetal angina indication Diltiazem drug_protein CACNG1",
      "Prinzmetal angina indication Diltiazem drug_protein CYP2C8",
      "Prinzmetal angina indication Diltiazem drug_protein ABCB1",
      "Prinzmetal angina indication Diltiazem drug_protein ALB",
      "Prinzmetal angina indication Diltiazem drug_protein ORM1",
      "Prinzmetal angina indication Diltiazem drug_protein CACNG1",
      "Prinzmetal angina indication Diltiazem drug_protein CYP2C8",
      "Prinzmetal angina indication Diltiazem drug_protein ABCB1",
      "Prinzmetal angina indication Diltiazem drug_protein ALB",
      "Prinzmetal angina indication Diltiazem drug_protein ORM1",
      "Prinzmetal angina indication Diltiazem drug_protein CACNG1",
      "Prinzmetal angina indication Diltiazem drug_protein CYP2C8",
      "Prinzmetal angina indication Diltiazem drug_protein ABCB1",
      "Prinzmetal angina indication Diltiazem drug_protein ALB",
      "Prinzmetal angina indication Diltiazem drug_protein ORM1",
      "Prinzmetal angina indication Diltiazem drug_protein CACNG1",
      "Prinzmetal angina indication Diltiazem drug_protein CYP2C8",
      "Prinzmetal angina indication Diltiazem drug_protein ABCB1",
      "Prinzmetal angina indication Diltiazem drug_protein ALB",
      "Prinzmetal angina indication Diltiazem drug_protein ORM1",
      "Prinzmetal angina indication Diltiazem drug_protein CACNG1"
    ],
    "llm_answer": "CYP2C8, ABCB1, ALB, ORM1, CACNG1",
    "pred_genes": [
      "CYP2C8",
      "ABCB1",
      "ALB",
      "ORM1",
      "CACNG1"
    ],
    "precision": 1.0,
    "recall": 0.07936507936507936,
    "f1": 0.14705882352941177
  },
  {
    "question": "治療 monosomy X 的藥物作用於哪些基因？",
    "gold_answers": [
      "GHR",
      "PRLR"
    ],
    "retrieved_context": [
      "monosomy X disease_protein GH1",
      "monosomy X disease_protein NOS2",
      "GH1 disease_protein monosomy X",
      "NOS2 disease_protein monosomy X",
      "autosomal monosomy disease_protein MSX1",
      "monosomy X indication Somatotropin drug_protein GHR",
      "monosomy X indication Somatotropin drug_protein PRLR",
      "monosomy X indication Somatotropin drug_protein GHR",
      "monosomy X indication Somatotropin drug_protein PRLR",
      "autosomal recessive familial Mediterranean fever indication Colchicine drug_protein CYP2C8",
      "autosomal recessive familial Mediterranean fever indication Colchicine drug_protein ABCB1",
      "autosomal recessive familial Mediterranean fever indication Colchicine drug_protein ALB",
      "autosomal recessive familial Mediterranean fever indication Colchicine drug_protein CYP2B6",
      "autosomal recessive familial Mediterranean fever indication Colchicine drug_protein CYP2E1"
    ],
    "llm_answer": "GHR, PRLR",
    "pred_genes": [
      "GHR",
      "PRLR"
    ],
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  {
    "question": "治療 benign recurrent intrahepatic cholestasis 的藥物作用於哪些基因？",
    "gold_answers": [
      "PRKCB",
      "PPP2CB",
      "SOD1",
      "PRKCA",
      "PPP2CA",
      "SEC14L2",
      "GSTP1",
      "ABCA1",
      "HMOX1",
      "NR1I2",
      "ALOX5",
      "NQO1",
      "SEC14L4",
      "GCLC",
      "PLTP",
      "TTPA",
      "GSTM3",
      "SCARB1",
      "DGKA",
      "ABCG1",
      "CYP3A4",
      "GSTO1",
      "GSTA2",
      "SEC14L3",
      "NPC1L1"
    ],
    "retrieved_context": [
      "benign recurrent intrahepatic cholestasis disease_protein TNF",
      "benign recurrent intrahepatic cholestasis disease_protein HSD3B7",
      "benign recurrent intrahepatic cholestasis disease_protein VIL1",
      "benign recurrent intrahepatic cholestasis disease_protein CCL7",
      "benign recurrent intrahepatic cholestasis disease_protein HNF1B",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein SOD1",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein SOD1",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein SOD1",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein SOD1",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CB",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein SOD1",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PRKCA",
      "benign recurrent intrahepatic cholestasis indication Vitamin E drug_protein PPP2CA"
    ],
    "llm_answer": "PRKCB, PPP2CB, SOD1, PRKCA, PPP2CA",
    "pred_genes": [
      "PRKCB",
      "PPP2CB",
      "SOD1",
      "PRKCA",
      "PPP2CA"
    ],
    "precision": 1.0,
    "recall": 0.2,
    "f1": 0.33333333333333337
  },
  {
    "question": "治療 thrombocythemia 的藥物作用於哪些基因？",
    "gold_answers": [
      "CYP1A2",
      "PDE3A"
    ],
    "retrieved_context": [
      "THBD disease_protein thrombomodulin-related bleeding disorder",
      "disseminated intravascular coagulation disease_protein THBD",
      "THBD disease_protein disseminated intravascular coagulation",
      "thrombomodulin-related bleeding disorder disease_protein THBD",
      "WAS disease_protein thrombocytopenia",
      "disseminated candidiasis indication Ketoconazole drug_protein CYP1A1",
      "disseminated candidiasis indication Ketoconazole drug_protein AR",
      "disseminated candidiasis indication Ketoconazole drug_protein CYP2C8",
      "disseminated candidiasis indication Ketoconazole drug_protein SHBG",
      "disseminated candidiasis indication Ketoconazole drug_protein CYP19A1"
    ],
    "llm_answer": "无",
    "pred_genes": [
      "无"
    ],
    "precision": 0.0,
    "recall": 0.0,
    "f1": 0
  },
  {
    "question": "治療 milker's nodule 的藥物作用於哪些基因？",
    "gold_answers": [
      "UGT1A4",
      "UGT1A1"
    ],
    "retrieved_context": [
      "NODAL disease_protein Marfan syndrome",
      "NODAL disease_protein heterotaxy, visceral, 1, X-linked",
      "NODAL disease_protein visceral heterotaxy",
      "NDN disease_protein mammary neoplasms, animal",
      "NODAL disease_protein situs inversus"
    ],
    "llm_answer": "TK, DNA polymerase",
    "pred_genes": [
      "TK",
      "DNA POLYMERASE"
    ],
    "precision": 0.0,
    "recall": 0.0,
    "f1": 0
  },
  {
    "question": "治療 Fabry disease 的藥物作用於哪些基因？",
    "gold_answers": [
      "GLA",
      "UGT1A1"
    ],
    "retrieved_context": [
      "Fabry disease disease_protein FADS2",
      "Fabry disease disease_protein FABP1",
      "Fabry disease disease_protein GLA",
      "INHBE disease_protein Fabry disease",
      "FADS2 disease_protein Fabry disease",
      "Fabry disease indication Migalastat drug_protein GLA",
      "Fabry disease indication Migalastat drug_protein UGT1A1",
      "Fabry disease indication Migalastat drug_protein GLA",
      "Fabry disease indication Migalastat drug_protein UGT1A1",
      "Fabry disease indication Migalastat drug_protein GLA",
      "Fabry disease indication Migalastat drug_protein UGT1A1"
    ],
    "llm_answer": "GLA, UGT1A1",
    "pred_genes": [
      "GLA",
      "UGT1A1"
    ],
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  }
]